CLOV vs OSCR: stock comparison and AI forecast
Clover Health Investments, Corp. /De (CLOV) and Oscar Health, Inc. (OSCR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CLOV Clover Health Investments, Corp. /De
- Price
- $4.82 +70.9% · 6M
- Market Cap
- $2.56B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
OSCR Oscar Health, Inc.
- Price
- $30.65 +46.9% · 6M
- Market Cap
- $9.46B
- P/E Ratio
- 12.3x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- OSCR is 3.7 times larger than CLOV by market capitalization ($9.46B against $2.56B).
- Over the last six months CLOV returned +70.9% and OSCR +46.9%.
- OSCR carries 3.50 times debt per unit of equity, against 0.93 times for CLOV.
- Both companies share the SEC industry classification Hospital & Medical Service Plans.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CLOV | OSCR |
|---|---|---|
| Market Cap | $2.56B | $9.46B |
| P/E Ratio | – | 12.26x |
| P/B Ratio | 6.55x | 4.26x |
| EPS | $-0.09 | $2.50 |
| Book Value/Share | $0.74 | $7.20 |
| Revenue/Share | $5.16 | $56.61 |
| FCF/Share | $0.25 | $13.42 |
Profitability & Margins
| Metric | CLOV | OSCR |
|---|---|---|
| ROE | – | 38.5% |
| ROA | – | 8.6% |
| ROIC | 3.0% | 34.6% |
| Operating Margin | 0.5% | 5.4% |
| Net Margin | – | 4.9% |
| EBT Margin | 0.0% | 5.2% |
| Tax Rate | – | 5.4% |
Financial Health
| Metric | CLOV | OSCR |
|---|---|---|
| Current Ratio | 1.55x | 1.14x |
| D/E Ratio | 0.93x | 3.50x |
| Financial Leverage | 1.93x | 4.50x |
| Interest Coverage | – | 16.8x |
| Working Capital | $189M | $1.01B |
Cash Flow
| Metric | CLOV | OSCR |
|---|---|---|
| Operating Cash Flow | $135M | $4.18B |
| Free Cash Flow | $132M | $4.14B |
| Capital Spending | -$3M | -$41M |
| OCF Growth YoY | – | 443.4% |
| FCF Growth YoY | – | 463.0% |
| FCF/Sales | 4.8% | 23.7% |
| CapEx/Sales | 0.1% | 0.2% |
Operational Efficiency
| Metric | CLOV | OSCR |
|---|---|---|
| Asset Turnover | 3.63x | 1.75x |
| Receivables Turnover | – | 57.6x |
| Fixed Assets Turnover | 353.4x | 159.8x |
| Days Sales Outstanding | – | 6 days |
Income Statement
| Metric | CLOV | OSCR |
|---|---|---|
| Total Revenue | $2.74B | $17.47B |
| Operating Income | $12M | $937M |
| Net Income | – | $855M |
| SG&A Expense | – | $2.63B |
Dividend & Shareholder Information
| Metric | CLOV | OSCR |
|---|---|---|
| Shares Outstanding | 531M | 309M |
CLOV vs OSCR: stock comparison and AI forecast
Which is bigger, CLOV or OSCR?
OSCR is 3.7 times larger than CLOV by market capitalization ($9.46B against $2.56B).
Which stock performed better over the last six months, CLOV or OSCR?
Over the last six months CLOV returned +70.9% and OSCR +46.9%.
Which one does Intratio's AI model rank higher, CLOV or OSCR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.